Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats

Proceedings of the Society for Experimental Biology and Medicine

Volumn 213, Issue 2, 1996, Pages 187-192

  Pete, Gina ^a   Hu, Yuange ^a   Walsh, Mary ^a   Sowers, James ^a   Dunbar, Joseph C ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; NITRIC OXIDE; SOMATOMEDIN C;

ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0029987359     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-213-44049     Document Type: Article

References (42)

1. Klapper DG, Svoboda ME, Van Wyk JJ. Sequence analysis of somatomedin C: conformation of identity with insulin-like growth factor-1. Endocrinology 112:2215-2217, 1983.
2. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor 1 and its structural homology with proinsulin. J Biol Chem 253:2769-2776, 1978.
3. Fryburg DA. Insulin-like growth factor-1 exerts growth hormone and insulin-like actions on human muscle protein metabolism. Am J Physiol 267:E331-E336, 1994.
4. Hussain MA, Schmitz AO, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch FR. Insulin-like growth factor 1 stimulates lipid oxidation and reduces protein oxidation, and improves insulin sensitivity in humans. J Clin Invest 92:2249-2256, 1993.
5. Thomas F, Knowles S, Owens P, Read L, Chandler SC, Gargosky S, Ballard F. Effects of full length and truncated insulin-like growth factor 1 on nitrogen balance and muscle protein metabolism in nitrogen restricted rats. J Endocrinol 128:97-105, 1991.
6. King GL, Goodman AD, Buzrey S, Masis A, Kahn CR. Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036, 1985.
7. Standley PR, Ram JL, Sowers JR. Insulin attenuation of vascular smooth muscle calcium responses in Zucker lean and obese rats. Endocrinology 133:1693-1699, 1993.
8. Hickner RC, Ungerstedt U, Henriksson J. Regulation of skeletal muscle blood flow during acute insulin-induced hypoglycemia in the rat. Diabetes 43:1340-1344, 1994.
9. Laakso M, Edelman SU, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 85:1844-1852, 1990.
10. Liang C-S, Doherty JW, Faillace R, Mackawa K, Arnold S, Gauras H, Hood WB Jr. Insulin infusion in conscious dogs. Effect on systemic and coronary hemodynamics, regional blood flows and plasma catecholamines. J Clin Invest 69:1321-1336, 1982.
11. Schultz-Klarr S, Wright-Richey J, Dunbar JC. Effect of insulin-induced hypoglycemia, 2-deoxyglucose-induced glucose cytopenia and hyperglycemia on cardiovascular tone in normal and diabetic rats. JAAMP 5:152-158, 1994.
12. Schultz-Klarr S, Wright-Richey J, Dunbar JC. Plasma glucose, insulin and cardiovascular responses after intravenous and intracerebroventricular injection of insulin, 2-deoxyglucose and glucose in rats. Diabetes Res Clin Pract 26:81-89, 1994.
13. Wright-Richey J, Schultz-Klarr S, Dunbar JC. The effect of ventralmedial hypothalamic lesion on the insulin-induced hypotensive response in normal rats. Acta Diabetol 31:91-97, 1994.
14. Harris KH, MacLeod KM. Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol 153:55, 1988.
15. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creagen MA. Impaired endothelium-dependent vasodilation in patient with insulin-dependent diabetes mellitus. Circulation 88:2510-2516, 1993.
16. Wu H-Y, Young YJ, Yue C-J, Kuang-Yuh C, Hsueh WA, Chan TM. Endothelial-dependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes 43:1027-1032, 1994.
17. Hofmann C, Goldfine ID, Whittaker JJ. The metabolic and mitogenic effects of both insulin and insulin-like growth factor are enhanced by transfection of insulin receptors into N1H3T3 fibroblast. J Biol Chem 264:8606-8611, 1989.
18. Hsueh WA, Anderson PW. Hypertension, the endothelial cell and the vascular complication of diabetes mellitus. Hypertension 20:253-263, 1992.
19. Milton SG, Knutson VP. Insulin receptor characterization and function in bovine aorta endothelial cells: Insulin degradation by a plasma membrane, protease-resistant insulin receptor. J Cell Physiol 157:333-343, 1993.
20. Motham CP, Duronio V, Jacobs S. Insulin like growth factor 1 receptor β-subunit heterogeneity. Evidence for hybrid tetramers composed of insulin like growth factor-1 and insulin receptor heterodimers. J Biol Chem 264:13238-13244, 1989.
21. Pillion D, Haskell J, Meezan E. Distinct receptors for insulin-like growth factor-1 in rat renal glomeruli and tubules. Am J Physiol 255:E504-E5I2, 1988.
22. Obberghen EV. Signalling through the insulin receptor and the insulin-like growth factor-1 receptor. Diabetologia 37:5125-S134, 1994.
23. Tartare S, Ballotti R, Van Oberrghen E. Interactions between heterologous receptor tyrosine kinases: Hormone stimulated insulin receptors activate unoccupied IGF-I receptors. FEBS Lett 295:219-225, 1991.
24. Copeland KC, Sreekuran K. Recombinant human insulin-like growth factor-1 increases forearm blood flow. J Clin Endocrinol Metab 79:230-232, 1994.
25. Elahi D, McAloon-Dyke M, Fukagawa NK. Modern Concepts in Insulin-Like Growth Factors. New York: Elsevier, pp219-224, 1991.
26. Kerr D, Tamborlane WV, Rife F, Sherwin RS. Effects of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin. J Clin Invest 91:141-147, 1993.
27. Prosser CG, Davis SR. Milking frequency alters the milk yield and mammary blood flow response to intra-mammary infusion of insulin-like growth factor-1 in the goat. J Endocrinol 135:311-316, 1992.
28. Liu L, Harding JE, Evans PC, Gluckman PD. Maternal insulin-like growth factor-1 infusion alters feto-placental carbohydrate and protein metabolism in pregnant sheep. Endocrinology 135:895-900, 1994.
29. Diez J, Ruilope LM, Rodicio JL. Is insulin-like growth factor I a determinant of renal hemodynamics in obesity hypertension. J Hypertens 11:5192-5193, 1993.
30. Hirschberg R, Kopple J. Evidence that insulin like growth factor 1 increases renal plasma flow and glomerular filtration rate in fasted rats. J Clin Invest 83:326-330, 1989.
31. Christensen NJ, Gunderson HJH, Hegedus L, Jacobsen E, Mogesen CE, Osderby R, Vittinghus E. Acute effect of insulin on plasma noradrenaline and the cardiovascular system. Metabolism 29:1138-1145, 1980.
32. Vollenweider P, Tappy L, Randin D. Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest 92:147-154, 1993.
33. Guler HP, Eckardt KU, Zapf J, Baver C, Froesch ER. Insulin like growth factor-1 increases glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 121:101-106, 1989.
34. Hirschberg R, Brunori G, Koppel J, Guler HP. Effects of insulin like growth factor-1 on renal function in normal men. Kidney Int 43:387-397, 1993.
35. Townsend RR, Yamamoto R, Nickels M, DiPette DJ, Nickols GA. Insulin enhances presser responses to norepinephrine in rat mesenteric vasculature. Hypertension 19(Suppl 11):II105-II110, 1992.
36. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252, 1991.
37. Baron AD, Brechtel G. Insulin differentially regulates systemic and skeletal muscle vascular resistance. Am J Physiol 265:E61-E67, 1993.
38. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: A possible line between insulin resistance and blood pressure. Hypertension 21:129-135, 1993.
39. Haylor J, Singh I, El-Nahas AM. Nitric oxide synthesis inhibitor prevents vasodilation by insulin like growth factor 1. Kidney Int 39:333-335, 1991.
40. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD. Insulin-mediated skeletal muscle vasodilation is nitric-oxide-dependent: A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994.
41. Ram JL, Fares MA, Standley PR, Sowers JR. Insulin inhibits vasopressin-elicited contraction of vascular smooth muscle cells. J Vasc Biol 4:250-254, 1993.
42. Yagi S, Takata S, Kiyokawa H, Yamamoto M, Noto Y, Ikeda T, Hattori N. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 37:1064-1067, 1992.